HA
Halozyme
HALO·NASDAQSan Diego CAFounded 1998900 employees
Large CapbiotechPublicOncologyMetabolicImmunology
Platform: ENHANZE
Market Cap
$11B
All Drugs
5
Clinical Trials
6
Failed / Terminated
0
FDA Approved
1
Stock Price & Catalysts (HALO)
Loading HALO stock data...
Drug Pipeline (5 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| HAL-9635 | HAL-9635 | Phase 2/3 | 1 | EZH2 | MSObesity | ||
| Elratapinarof | HAL-6224 | Phase 2 | 1 | C5 | ET | ||
| HAL-1232 | HAL-1232 | Approved | 1 | C5 | Breast Ca | ||
| Sovarasimod | HAL-5576 | Phase 1/2 | 1 | WEE1 | CeliacCKD | ||
| HAL-996 | HAL-996 | Phase 1/2 | 2 | BCL-2 | PompeHuntington's |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)